Showing results (331-340 of 655) with videos related to
Sort By:
Pageof 66
Journal of Managed Care Pharmacy : JMCP|January 25, 2014
Adherence to national recommendations for safe methotrexate dispensing in community pharmaciesEllen S Koster, Joelle C D Walgers, Mariska C J van Grinsven, et al.Journal of Managed Care Pharmacy : JMCP|November 7, 2012
Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairmentBarbara J Zarowitz, Terrence O'SheaJournal of Managed Care Pharmacy : JMCP|November 7, 2012
Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer painKathryn P Anastassopoulos, Wing Chow, Crisanta I Tapia, et al.Journal of Managed Care Pharmacy : JMCP|January 3, 2008
Psychosocial and cultural contributions to depression in women: considerations for women midlife and beyondGwendolyn Puryear KeitaJournal of Managed Care Pharmacy : JMCP|July 4, 2008
Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organizationMatthew P Mitchell, Kenneth Schaecher, H Eric Cannon, et al.Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP controlLawrence G HunsickerJournal of Managed Care Pharmacy : JMCP|January 15, 2004
Cost-effectiveness analysis and the formulary decision-making processZhixiao Wang, J Warren Salmon, Surrey M WaltonJournal of Managed Care Pharmacy : JMCP|January 26, 2005
Applications of disease benchmarks and case presentationsMichael W PillJournal of Managed Care Pharmacy : JMCP|February 26, 2011
Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plansAnna Vlahiotis, Scott T Devine, Jeff Eichholz, et al.Journal of Managed Care Pharmacy : JMCP|June 4, 2010
Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid ProgramJason C Simeone, Rita M Marcoux, Brian J QuilliamPageof 66